Pelican Cancer Foundation

Pelican Cancer Foundation

  • Facebook
  • Instagram
  • Twitter
  • YouTube
DONATE NOW
  • Home
  • About Us
    • About us
    • What we do
      • Bowel cancer
      • Colorectal Liver Metastases
      • Pseudomyxoma peritonei
      • Our Research
      • Our achievements
      • What’s next?
    • Who we are
      • Our board
      • Our team
      • Pelican Patrons
      • Job opportunities
    • Support Us
    • Keep in touch
    • Our annual accounts
  • Workshops
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
    • What clinicians say about our courses
    • Faculty
    • Our sponsors
    • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Films
  • Research
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Previous Research Areas
      • Prostate Cancer Research
        • Prostate cancer
        • Focal therapy and HIFU research
        • MRI research for prostate cancer
        • Prostate cancer colloquiums
        • FORECAST
        • Trachtomap
        • Papers of interest
      • Bladder cancer research
        • Bladder cancer
        • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for researchers
      • Peer review process
      • Research review panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Pseudomyxoma peritonei
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Why donate to Pelican?
      • Donate shares
      • Donate in memory
      • How your donations are spent
    • Fundraising
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
      • Our events
    • Leaving a Legacy
    • Volunteering Opportunities
    • Could you host a Pelican Talk?
    • Become a Corporate Charity Partner
    • Pelican Film Society
  • Shop
  • Events
  • Contact us

Bladder cancer research

Pelican no longer funds research into bladder cancer.

 

Pelican Cancer Foundation supports research that informs and improves bladder cancer treatment today.

Bladder cancer is the seventh most common cancer in the UK, the fourth in males, and it accounts for 3% of all deaths from cancer. In 2011 10,399 new cases of bladder cancer were diagnosed. There are various different types of bladder cancer including transitional cell bladder cancer. Transitional cell bladder cancer is the most common form and affects 90% of bladder cancer patients. Non-muscle invasive (superficial) bladder cancer is a form of early stage transitional cell bladder cancer where the cancer has not yet penetrated the deeper walls of the bladder and is confined to the inner lining, or just below.

The Basingstoke Department of Urology has a special interest in the treatment of superficial bladder cancer and has helped to develop new techniques for treating this condition, including intraoperative administration of chemotherapy into the bladder, microwave hyperthermia. The department is actively involved in National trials in bladder cancer and has a research link with the University of Reading.

Pelican Cancer Foundation Follow

Driving innovation and advancing surgery to help patients live well, for longer.

Pelican_Cancer
pelican_cancer Pelican Cancer Foundation @pelican_cancer ·
28 Nov

👇 Available now - http://pelicancancervideos.org
🎥Complexity and decision making for patients with low rectal cancer

Mr Mark Gudgeon, Professor Heald & Mr Moran
@MGudgeon @ProfessorHeald @Brendan92855812

Reply on Twitter 1597119096096784384 Retweet on Twitter 1597119096096784384 2 Like on Twitter 1597119096096784384 2 Twitter 1597119096096784384
pelican_cancer Pelican Cancer Foundation @pelican_cancer ·
26 Nov

👇 Available now - http://pelicancancervideos.org
🎥Complexity and decision making for patients with low rectal cancer

Mr Mark Gudgeon, Professor Heald & Mr Moran
@MGudgeon @ProfessorHeald @Brendan92855812

Reply on Twitter 1596393313757642752 Retweet on Twitter 1596393313757642752 1 Like on Twitter 1596393313757642752 1 Twitter 1596393313757642752
pelican_cancer Pelican Cancer Foundation @pelican_cancer ·
25 Nov

👇 Available now - http://pelicancancervideos.org
🎥Complexity and decision making for patients with low rectal cancer

Mr Mark Gudgeon, Professor Heald & Mr Moran
@MGudgeon @ProfessorHeald @Brendan92855812

Reply on Twitter 1596159243203350528 Retweet on Twitter 1596159243203350528 2 Like on Twitter 1596159243203350528 5 Twitter 1596159243203350528
Load More...

To view our privacy policy - click here.
Registered charity no: 1141911

Copyright © 2023 · Outreach Pro Theme on Genesis Framework · WordPress · Log in